# Bernard Escudier

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bernard-escudier/

## Facts

| Field | Value |
| --- | --- |
| Citations | 90,434 |
| Field | Renal cell carcinoma treatment |
| h-index | 121 |
| i10-index | 519 |
| Last Known Institution | Institut Gustave Roussy |
| OpenAlex ID | https://openalex.org/A5049672639 |
| ORCID iD | https://orcid.org/0000-0002-4626-0479 |
| Works | 1,140 |

## Researcher papers

- [Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-versus-everolimus-in-advanced-renal-cell-carcinoma/)
- [Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors](https://scholariq.org/papers/gut-microbiome-influences-efficacy-of-pd-1-based-immunotherapy-against/)
- [Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-plus-ipilimumab-versus-sunitinib-in-advanced-renal-cell-carcinoma/)
- [Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-plus-cabozantinib-versus-sunitinib-for-advanced-renal-cell-carcinoma/)
- [Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma](https://scholariq.org/papers/clinical-activity-and-molecular-correlates-of-response-to-atezolizumab-alone-or/)
- [Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma](https://scholariq.org/papers/sunitinib-alone-or-after-nephrectomy-in-metastatic-renal-cell-carcinoma/)
- [A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies](https://scholariq.org/papers/a-16-gene-assay-to-predict-recurrence-after-surgery-in-localised-renal-cell/)
- [Phosphostim-Activated γδ T Cells Kill Autologous Metastatic Renal Cell Carcinoma](https://scholariq.org/papers/phosphostim-activated-t-cells-kill-autologous-metastatic-renal-cell-carcinoma/)

## Researcher topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)

## Researcher university

- [Institut Gustave Roussy](https://scholariq.org/institutions/institut-gustave-roussy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.